iSpecimen Inc.
ISPC · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $0 | $1 | $1 | $1 |
| % Growth | -85.1% | -32.6% | -28.3% | – |
| Cost of Goods Sold | $0 | $0 | $1 | $1 |
| Gross Profit | -$0 | $0 | $0 | $0 |
| % Margin | -91.9% | 37.7% | 37.8% | 10.3% |
| R&D Expenses | $0 | $1 | $1 | $1 |
| G&A Expenses | $1 | $1 | $1 | $4 |
| SG&A Expenses | $2 | $1 | $1 | $6 |
| Sales & Mktg Exp. | $1 | $0 | $0 | $3 |
| Other Operating Expenses | $1 | $0 | $0 | -$1 |
| Operating Expenses | $3 | $2 | $2 | $6 |
| Operating Income | -$3 | -$2 | -$2 | -$6 |
| % Margin | -2,655.2% | -255.4% | -154.9% | -395.8% |
| Other Income/Exp. Net | $0 | $1 | -$0 | -$0 |
| Pre-Tax Income | -$3 | -$1 | -$2 | -$6 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$3 | -$1 | -$2 | -$6 |
| % Margin | -2,608.7% | -146.9% | -156.8% | -409.8% |
| EPS | -0.48 | -0.42 | -2.33 | -8.51 |
| % Growth | -14.3% | 82% | 72.6% | – |
| EPS Diluted | -0.48 | -0.42 | -2.33 | -8.51 |
| Weighted Avg Shares Out | 6 | 2 | 1 | 1 |
| Weighted Avg Shares Out Dil | 6 | 2 | 1 | 1 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $1 |
| EBITDA | -$2 | -$1 | -$1 | -$5 |
| % Margin | -2,211.4% | -86.2% | -114% | -358.9% |